Passive immunization against cytomegalovirus during pregnancy [7]

New England Journal of Medicine

Volumn 353, Issue 26, 2005, Pages 2818-

  Silverman, Neil S ^a   Puliyanda, Dechu ^b   Lehman, Debbie ^b  

^a Center for Fetal Medicine and Women's Ultrasound   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYTOMEGALOVIRUS ANTIBODY; HYPERIMMUNE GLOBULIN; GANCICLOVIR; IMMUNOGLOBULIN;

AMNIOCENTESIS; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; HUMAN; LETTER; PASSIVE IMMUNIZATION; PREGNANCY DISORDER; PRIORITY JOURNAL; VIRUS SHEDDING; CYTOMEGALIC INCLUSION BODY DISEASE; FEMALE; FETUS DISEASE; NEWBORN; NOTE; PREGNANCY; PREGNANCY COMPLICATION;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FETAL DISEASES; GANCICLOVIR; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 29544439974     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc052894     Document Type: Letter

References (3)

1. Nigro G, Adler SP, La Torre R, Best AM. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005;353:1350-62.
2. Puliyanda DP, Silverman NS, Lehman D, et al. Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient. Transpl Infect Dis 2005;7:71-4.
3. Watts DH. Management of human immunodeficiency virus infection in pregnancy. N Engl J Med 2002;346:1879-91.